Cholesterol loading suppresses the atheroinflammatory gene polarization of human macrophages induced by colony stimulating factors. 2021

Jani Lappalainen, and Nicolas Yeung, and Su D Nguyen, and Matti Jauhiainen, and Petri T Kovanen, and Miriam Lee-Rueckert
Wihuri Research Institute, Helsinki, Finland.

In atherosclerotic lesions, blood-derived monocytes differentiate into distinct macrophage subpopulations, and further into cholesterol-filled foam cells under a complex milieu of cytokines, which also contains macrophage-colony stimulating factor (M-CSF) and granulocyte-macrophage-colony stimulating factor (GM-CSF). Here we generated human macrophages in the presence of either M-CSF or GM-CSF to obtain M-MØ and GM-MØ, respectively. The macrophages were converted into cholesterol-loaded foam cells by incubating them with acetyl-LDL, and their atheroinflammatory gene expression profiles were then assessed. Compared with GM-MØ, the M-MØ expressed higher levels of CD36, SRA1, and ACAT1, and also exhibited a greater ability to take up acetyl-LDL, esterify cholesterol, and become converted to foam cells. M-MØ foam cells expressed higher levels of ABCA1 and ABCG1, and, correspondingly, exhibited higher rates of cholesterol efflux to apoA-I and HDL2. Cholesterol loading of M-MØ strongly suppressed the high baseline expression of CCL2, whereas in GM-MØ the low baseline expression CCL2 remained unchanged during cholesterol loading. The expression of TNFA, IL1B, and CXCL8 were reduced in LPS-activated macrophage foam cells of either subtype. In summary, cholesterol loading converged the CSF-dependent expression of key genes related to intracellular cholesterol balance and inflammation. These findings suggest that transformation of CSF-polarized macrophages into foam cells may reduce their atheroinflammatory potential in atherogenesis.

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D009000 Monocytes Large, phagocytic mononuclear leukocytes produced in the vertebrate BONE MARROW and released into the BLOOD; contain a large, oval or somewhat indented nucleus surrounded by voluminous cytoplasm and numerous organelles. Monocyte
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D002784 Cholesterol The principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils. Epicholesterol
D003115 Colony-Stimulating Factors Glycoproteins found in a subfraction of normal mammalian plasma and urine. They stimulate the proliferation of bone marrow cells in agar cultures and the formation of colonies of granulocytes and/or macrophages. The factors include INTERLEUKIN-3; (IL-3); GRANULOCYTE COLONY-STIMULATING FACTOR; (G-CSF); MACROPHAGE COLONY-STIMULATING FACTOR; (M-CSF); and GRANULOCYTE-MACROPHAGE COLONY-STIMULATING FACTOR; (GM-CSF). MGI-1,Macrophage-Granulocyte Inducer,Colony Stimulating Factor,Colony-Stimulating Factor,MGI-1 Protein,Myeloid Cell-Growth Inducer,Protein Inducer MGI,Cell-Growth Inducer, Myeloid,Colony Stimulating Factors,Inducer, Macrophage-Granulocyte,Inducer, Myeloid Cell-Growth,MGI 1 Protein,MGI, Protein Inducer,Macrophage Granulocyte Inducer,Myeloid Cell Growth Inducer
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D050197 Atherosclerosis A thickening and loss of elasticity of the walls of ARTERIES that occurs with formation of ATHEROSCLEROTIC PLAQUES within the ARTERIAL INTIMA. Atherogenesis,Atherogeneses,Atheroscleroses
D061251 Primary Cell Culture The initial culturing of cells derived directly from fresh TISSUES. Cell Culture, Primary,Cell Cultures, Primary,Primary Cell Cultures

Related Publications

Jani Lappalainen, and Nicolas Yeung, and Su D Nguyen, and Matti Jauhiainen, and Petri T Kovanen, and Miriam Lee-Rueckert
January 1995, European cytokine network,
Jani Lappalainen, and Nicolas Yeung, and Su D Nguyen, and Matti Jauhiainen, and Petri T Kovanen, and Miriam Lee-Rueckert
February 2001, Scandinavian journal of immunology,
Jani Lappalainen, and Nicolas Yeung, and Su D Nguyen, and Matti Jauhiainen, and Petri T Kovanen, and Miriam Lee-Rueckert
January 2000, Life sciences,
Jani Lappalainen, and Nicolas Yeung, and Su D Nguyen, and Matti Jauhiainen, and Petri T Kovanen, and Miriam Lee-Rueckert
December 1972, Lancet (London, England),
Jani Lappalainen, and Nicolas Yeung, and Su D Nguyen, and Matti Jauhiainen, and Petri T Kovanen, and Miriam Lee-Rueckert
January 1991, Journal of biological regulators and homeostatic agents,
Jani Lappalainen, and Nicolas Yeung, and Su D Nguyen, and Matti Jauhiainen, and Petri T Kovanen, and Miriam Lee-Rueckert
February 1990, Arzneimittel-Forschung,
Jani Lappalainen, and Nicolas Yeung, and Su D Nguyen, and Matti Jauhiainen, and Petri T Kovanen, and Miriam Lee-Rueckert
January 2006, Respirology (Carlton, Vic.),
Jani Lappalainen, and Nicolas Yeung, and Su D Nguyen, and Matti Jauhiainen, and Petri T Kovanen, and Miriam Lee-Rueckert
July 2002, International journal of hematology,
Jani Lappalainen, and Nicolas Yeung, and Su D Nguyen, and Matti Jauhiainen, and Petri T Kovanen, and Miriam Lee-Rueckert
July 1989, Journal of chemotherapy (Florence, Italy),
Jani Lappalainen, and Nicolas Yeung, and Su D Nguyen, and Matti Jauhiainen, and Petri T Kovanen, and Miriam Lee-Rueckert
January 2014, Frontiers in immunology,
Copied contents to your clipboard!